Eupraxia Pharmaceuticals Inc. (EPRX)

NASDAQ: EPRX · IEX Real-Time Price · USD

2.520

+0.050 (2.02%)

At close: Jul 2, 2024, 3:57 PM

2.551

+0.031 (1.23%)

After-hours: Jul 2, 2024, 5:02 PM EDT

Eupraxia Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022
Net Income	-28.97	-18.99
Depreciation & Amortization	0.16	0.15
Share-Based Compensation	1.41	1.43
Other Operating Activities	6.71	3.01
Operating Cash Flow	-20.68	-14.4
Capital Expenditures	-0.07	-0.24
Change in Investments	0	10.07
Investing Cash Flow	-0.07	9.83
Share Issuance / Repurchase	15.89	10.64
Debt Issued / Paid	-0.14	-0.14
Other Financing Activities	5.27	0.31
Financing Cash Flow	21.01	10.8
Exchange Rate Effect	0.82	-0.51
Net Cash Flow	0.26	6.24
Free Cash Flow	-20.76	-14.63
Free Cash Flow Per Share	-0.86	-0.76

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).